Rilotumumab

Rilotumumab (AMG 102) is a monoclonal antibody targeting hepatocyte growth factor that inhibits HGF/ MET-driven signaling. Rilotumumab has antitumor effects and can be used to study castration-resistant prostate cancer (CRPC) and gastric cancer.

Product Specifications

CAS Number

872514-65-3

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

C-Met/HGFR

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

abx975655-01 150 µg

Mouse RWDD1 shRNA Plasmid

Ask

View Details

abx975655-02 300 µg

Mouse RWDD1 shRNA Plasmid

Ask

View Details

MBS9632316-01 1 mg

ART1 Blocking Peptide

Ask

View Details

MBS9632316-02 5x 1 mg

ART1 Blocking Peptide

Ask

View Details

FAB3195X 0.1 mL

Mouse Monoclonal TRA-1-85/CD147 Antibody (TRA-1-85) [Alexa Fluor 532]

Ask

View Details

NBP1-77059PCP 0.1 mL

Rabbit Polyclonal Polypeptide GalNac Transferase 10/GALNT10 Antibody [PerCP]

Ask

View Details